Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry ...

"We are excited to welcome Ambry to the Tempus team as we work together to improve patient outcomes and transform treatment journeys through the power of technology." As previously disclosed in ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics ...

The Minnesota Vikings announced they have signed CB Ambry Thomas to a futures contract. The #Vikings have signed CB Ambry Thomas to a reserve/future free agent contract. — Minnesota Vikings ...

They also inked cornerback Ambry Thomas to a reserve/futures contract after signing over a dozen players to such deals on Wednesday. The #Vikings have re-signed DL Jalen Redmond. pic.twitter.com ...

Growth is forecast to continue in the 23-25% range in eFY25. Tempus is expecting to close the Ambry acquisition in Q1 2025. The deal will be accretive to Tempus' adjusted EBITDA margin while ...

Rumors have been floating around for months that Apple might launch a brand-new iPhone model this year: the so-called iPhone Air, a new, super-thin iPhone that may mark the first big design shift ...

Feb. 10, 2025 — New research has found exposure to outdoor air pollution and extreme temperatures during pregnancy may increase the risk of prolonged pregnancy, offering new insights into the ...

Highlights,Acquisition Deal Finalized:,Tempus AI acquired,Ambry Genetics,for,$600 million,in cash and stock.,Strategic Expansion:,The deal strengthens Tempus’ role in,AI-driven precision medicine and ...